DA-0218
Modify Date: 2025-08-25 23:12:04
DA-0218 structure
|
Common Name | DA-0218 | ||
|---|---|---|---|---|
| CAS Number | 1081317-31-8 | Molecular Weight | 543.711 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H37N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DA-0218DA-0218 (DA0218) is a novel potent, selective Nav1.7 inhibitor, inhibits sodium currents in Nav1.7-expressing human embryonic kidney 293 cells with IC50 of 0.74 uM.DA-0218 has no effect on sodium currents in Nav1.5-transfected human embryonic kidney 293 cells in patch-clamp experiments.DA-0218 shows analgesic activity predominantly in phase II in formalin-induced inflammatory pain mouse model.DA-0218 produced acute reduction in paclitaxel-induced mechanical allodynia, and inhibited histamine-induced acute itch and lymphoma-induced chronic itch. |
| Name | DA-0218 |
|---|
| Description | DA-0218 (DA0218) is a novel potent, selective Nav1.7 inhibitor, inhibits sodium currents in Nav1.7-expressing human embryonic kidney 293 cells with IC50 of 0.74 uM.DA-0218 has no effect on sodium currents in Nav1.5-transfected human embryonic kidney 293 cells in patch-clamp experiments.DA-0218 shows analgesic activity predominantly in phase II in formalin-induced inflammatory pain mouse model.DA-0218 produced acute reduction in paclitaxel-induced mechanical allodynia, and inhibited histamine-induced acute itch and lymphoma-induced chronic itch. |
|---|---|
| References | 1. Sharat Chandra, et al. Anesthesiology. 2020 Sep;133(3):611-627. |
| Molecular Formula | C36H37N3O2 |
|---|---|
| Molecular Weight | 543.711 |